BiomX acquires 10% stake in Motomea and licenses drone-testing technology
BiomX acquired a 10% minority stake in Motomea for cash and restricted shares, alongside an exclusive licence for drone-testing solutions and an option to acquire control.
Evidence notes
- Motomea develops electric-motor and powertrain test systems spanning development, production validation and predictive maintenance.
- The licence gives BiomX exclusive rights to commercialise Motomea technology for drone-testing applications.
- The transaction is a completed minority investment; the option to acquire control has not been exercised.
Company context
Motomea develops electric-motor and powertrain test systems for research, end-of-line validation and predictive maintenance. Formerly MEA Testing Systems, the company supplies regenerative and inertial dynamometer platforms across automotive, aerospace, industrial and robotic applications.